The Readout Loud
A podcast by STAT - Thursdays
350 Episodes
-
228: A surprise success in Alzheimer's and how FDA history seeded modern controversy
Published: 9/29/2022 -
227: Biden's Covid declaration, twilight of the SPAC, & genome editing 2.0
Published: 9/22/2022 -
226: Pharma's telehealth gold mine, the return of the biotech IPO, & a merger deferred
Published: 9/15/2022 -
225: Illumina's $8 billion limbo, a new treatment for ALS, & Emirati biotech funding
Published: 9/8/2022 -
224: The anti-aging research boom, the Godfather of biotech, & the future of Biogen
Published: 9/1/2022 -
223: Fauci's non-retirement, grading biotech VCs, & a bellwether IPO
Published: 8/25/2022 -
222: Private equity in autism care, a watershed FDA approval, & the future of ALS treatment
Published: 8/18/2022 -
221: Big egos in Big Science, the return of Merger Monday, & the fallout over drug pricing
Published: 8/11/2022 -
220: The last-minute push for drug pricing reform, Alnylam's success, and Sarepta's gamble
Published: 8/4/2022 -
219: Helen Branswell on monkeypox, plus: an FDA controversy and fake Alzheimer's data
Published: 7/28/2022 -
218: Well-paid CEOs, behind the scenes at Moderna, & Biogen's CEO search
Published: 7/21/2022 -
217: CRISPR for the heart, biotech's recovery, & what it means to be a 'hot girl'
Published: 7/14/2022 -
216: VC malaise, FDA confusion, & yet another Alzheimer's debate
Published: 7/7/2022 -
215: Medical privacy post-Roe, fixing clinical trials, & the next Covid vaccines
Published: 6/30/2022 -
214: Juul's doomsday, Merck's buyout plans, & the next Theranos verdict
Published: 6/23/2022 -
213: How the Fed affects biotech, Paul Offit on vaccines for kids, & another Alzheimer's setback
Published: 6/16/2022 -
212: Applause-worthy cancer data, the long wait for Novavax, & the next FDA controversy
Published: 6/9/2022 -
211: Biotech's catch-22, a $100 genome, & dealing with monkeypox
Published: 6/2/2022 -
210: Covid vaccines for the youngest kids, ASCO preview, & a biotech CEO’s arrest on murder charges
Published: 5/26/2022 -
Episode 209: Mysterious infections, dwindling Covid funds, & Shkreli out of prison
Published: 5/19/2022
STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.